nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Ifosfamide—testicular cancer	0.154	0.239	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.154	0.239	CbGbCtD
Lercanidipine—CYP3A5—Ifosfamide—testicular cancer	0.116	0.179	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—testicular cancer	0.0553	0.0856	CbGbCtD
Lercanidipine—CYP3A4—Ifosfamide—testicular cancer	0.0451	0.0699	CbGbCtD
Lercanidipine—CYP2D6—Vinblastine—testicular cancer	0.0376	0.0583	CbGbCtD
Lercanidipine—CYP3A4—Vinblastine—testicular cancer	0.0239	0.0371	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—testicular cancer	0.0231	0.0358	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—testicular cancer	0.0216	0.0334	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—testicular cancer	0.0147	0.0228	CbGbCtD
Lercanidipine—Pancytopenia—Doxorubicin—testicular cancer	0.000331	0.000934	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—testicular cancer	0.00033	0.000932	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00033	0.000931	CcSEcCtD
Lercanidipine—Body temperature increased—Cisplatin—testicular cancer	0.00033	0.00093	CcSEcCtD
Lercanidipine—Fatigue—Etoposide—testicular cancer	0.00033	0.00093	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000329	0.000929	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—testicular cancer	0.000327	0.000924	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—testicular cancer	0.000327	0.000924	CcSEcCtD
Lercanidipine—Constipation—Etoposide—testicular cancer	0.000327	0.000922	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—testicular cancer	0.000326	0.00092	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—testicular cancer	0.000322	0.000909	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—testicular cancer	0.000322	0.000908	CcSEcCtD
Lercanidipine—Dizziness—Ifosfamide—testicular cancer	0.00032	0.000903	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—testicular cancer	0.000318	0.000898	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000318	0.000898	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000318	0.000896	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—testicular cancer	0.000316	0.000891	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—testicular cancer	0.000315	0.000889	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—testicular cancer	0.000314	0.000885	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—testicular cancer	0.000313	0.000884	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—testicular cancer	0.000313	0.000882	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000308	0.000869	CcSEcCtD
Lercanidipine—Vomiting—Ifosfamide—testicular cancer	0.000308	0.000868	CcSEcCtD
Lercanidipine—Hypersensitivity—Cisplatin—testicular cancer	0.000307	0.000867	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—testicular cancer	0.000306	0.000862	CcSEcCtD
Lercanidipine—Rash—Ifosfamide—testicular cancer	0.000305	0.000861	CcSEcCtD
Lercanidipine—Dermatitis—Ifosfamide—testicular cancer	0.000305	0.00086	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—testicular cancer	0.000305	0.00086	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000305	0.00086	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—testicular cancer	0.000304	0.000857	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—testicular cancer	0.000303	0.000855	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—testicular cancer	0.000303	0.000855	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—testicular cancer	0.000302	0.000853	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—testicular cancer	0.000302	0.000852	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—testicular cancer	0.000302	0.000852	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—testicular cancer	0.000302	0.000851	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—testicular cancer	0.000301	0.00085	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—testicular cancer	0.0003	0.000848	CcSEcCtD
Lercanidipine—Asthenia—Cisplatin—testicular cancer	0.000299	0.000844	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—testicular cancer	0.000299	0.000844	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—testicular cancer	0.000298	0.00084	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—testicular cancer	0.000297	0.000838	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—testicular cancer	0.000296	0.000836	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—testicular cancer	0.000296	0.000834	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000294	0.000829	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—testicular cancer	0.000292	0.000825	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—testicular cancer	0.000291	0.000821	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—testicular cancer	0.00029	0.000819	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—testicular cancer	0.00029	0.000818	CcSEcCtD
Lercanidipine—Nausea—Ifosfamide—testicular cancer	0.000287	0.000811	CcSEcCtD
Lercanidipine—Diarrhoea—Cisplatin—testicular cancer	0.000285	0.000805	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—testicular cancer	0.000285	0.000804	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—testicular cancer	0.000285	0.000803	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—testicular cancer	0.000282	0.000796	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—testicular cancer	0.000282	0.000795	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—testicular cancer	0.000282	0.000794	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—testicular cancer	0.000281	0.000793	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—testicular cancer	0.000281	0.000791	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—testicular cancer	0.000281	0.000791	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—testicular cancer	0.00028	0.00079	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—testicular cancer	0.00028	0.00079	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—testicular cancer	0.00028	0.000789	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—testicular cancer	0.000279	0.000787	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000276	0.000777	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—testicular cancer	0.000275	0.000775	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—testicular cancer	0.000275	0.000775	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—testicular cancer	0.000274	0.000774	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000274	0.000774	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—testicular cancer	0.000274	0.000772	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—testicular cancer	0.000274	0.000772	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—testicular cancer	0.000272	0.000768	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—testicular cancer	0.000272	0.000767	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—testicular cancer	0.00027	0.000763	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—testicular cancer	0.000266	0.000752	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—testicular cancer	0.000265	0.000748	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—testicular cancer	0.000264	0.000746	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—testicular cancer	0.000264	0.000745	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—testicular cancer	0.000264	0.000744	CcSEcCtD
Lercanidipine—Rash—Cisplatin—testicular cancer	0.000263	0.000742	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—testicular cancer	0.000263	0.000741	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—testicular cancer	0.000263	0.000741	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—testicular cancer	0.000263	0.000741	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—testicular cancer	0.000262	0.000738	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—testicular cancer	0.000261	0.000736	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—testicular cancer	0.00026	0.000734	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—testicular cancer	0.00026	0.000734	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—testicular cancer	0.000259	0.000731	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—testicular cancer	0.000259	0.000731	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—testicular cancer	0.000259	0.000731	CcSEcCtD
Lercanidipine—Tension—Epirubicin—testicular cancer	0.000258	0.000727	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—testicular cancer	0.000257	0.000725	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—testicular cancer	0.000255	0.000719	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—testicular cancer	0.000253	0.000714	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—testicular cancer	0.000253	0.000714	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—testicular cancer	0.000253	0.000713	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—testicular cancer	0.000252	0.000712	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—testicular cancer	0.000252	0.000711	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—testicular cancer	0.000252	0.000711	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000251	0.000709	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—testicular cancer	0.000248	0.000699	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—testicular cancer	0.000247	0.000698	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—testicular cancer	0.000247	0.000696	CcSEcCtD
Lercanidipine—Cough—Methotrexate—testicular cancer	0.000245	0.000691	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—testicular cancer	0.000244	0.00069	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—testicular cancer	0.000244	0.000687	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—testicular cancer	0.000243	0.000686	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—testicular cancer	0.000243	0.000685	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—testicular cancer	0.000243	0.000685	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—testicular cancer	0.000243	0.000684	CcSEcCtD
Lercanidipine—Rash—Etoposide—testicular cancer	0.000241	0.00068	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—testicular cancer	0.000241	0.000679	CcSEcCtD
Lercanidipine—Headache—Etoposide—testicular cancer	0.000239	0.000675	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—testicular cancer	0.000239	0.000674	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—testicular cancer	0.000239	0.000674	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—testicular cancer	0.000239	0.000674	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—testicular cancer	0.000238	0.000672	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—testicular cancer	0.000238	0.000671	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000237	0.000669	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—testicular cancer	0.000237	0.000668	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—testicular cancer	0.000236	0.000666	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—testicular cancer	0.000236	0.000666	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—testicular cancer	0.000236	0.000665	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—testicular cancer	0.000235	0.000664	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—testicular cancer	0.000234	0.000659	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—testicular cancer	0.000232	0.000654	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—testicular cancer	0.000231	0.000651	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—testicular cancer	0.000231	0.000651	CcSEcCtD
Lercanidipine—Cough—Epirubicin—testicular cancer	0.000229	0.000646	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—testicular cancer	0.000229	0.000646	CcSEcCtD
Lercanidipine—Nausea—Etoposide—testicular cancer	0.000227	0.00064	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000225	0.000636	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—testicular cancer	0.000225	0.000633	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—testicular cancer	0.000224	0.000633	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—testicular cancer	0.000224	0.000632	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—testicular cancer	0.000223	0.00063	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—testicular cancer	0.000223	0.00063	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—testicular cancer	0.000223	0.00063	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—testicular cancer	0.000223	0.000628	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—testicular cancer	0.000222	0.000627	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000222	0.000626	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—testicular cancer	0.000221	0.000624	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—testicular cancer	0.000221	0.000623	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—testicular cancer	0.000219	0.000618	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—testicular cancer	0.000219	0.000617	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—testicular cancer	0.000218	0.000616	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—testicular cancer	0.000218	0.000616	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—testicular cancer	0.000218	0.000615	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—testicular cancer	0.000216	0.000609	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—testicular cancer	0.000215	0.000606	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—testicular cancer	0.000214	0.000604	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—testicular cancer	0.000213	0.000602	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—testicular cancer	0.000212	0.000598	CcSEcCtD
Lercanidipine—Shock—Epirubicin—testicular cancer	0.000211	0.000595	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—testicular cancer	0.00021	0.000593	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—testicular cancer	0.00021	0.000592	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—testicular cancer	0.000209	0.00059	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000209	0.000588	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—testicular cancer	0.000208	0.000587	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—testicular cancer	0.000207	0.000584	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—testicular cancer	0.000207	0.000584	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—testicular cancer	0.000207	0.000583	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—testicular cancer	0.000207	0.000583	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—testicular cancer	0.000207	0.000583	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—testicular cancer	0.000206	0.000581	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—testicular cancer	0.000206	0.00058	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000205	0.000579	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—testicular cancer	0.000204	0.000576	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—testicular cancer	0.000204	0.000576	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—testicular cancer	0.000204	0.000576	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—testicular cancer	0.000204	0.000574	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—testicular cancer	0.000202	0.000571	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—testicular cancer	0.000202	0.000569	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—testicular cancer	0.0002	0.000565	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—testicular cancer	0.0002	0.000564	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—testicular cancer	0.000199	0.000561	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000198	0.000558	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—testicular cancer	0.000197	0.000557	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000195	0.000551	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—testicular cancer	0.000195	0.00055	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—testicular cancer	0.000194	0.000548	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000194	0.000548	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—testicular cancer	0.000194	0.000547	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—testicular cancer	0.000193	0.000546	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—testicular cancer	0.000193	0.000543	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—testicular cancer	0.000192	0.000543	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000192	0.000541	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—testicular cancer	0.000191	0.000539	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—testicular cancer	0.00019	0.000537	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—testicular cancer	0.000189	0.000533	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—testicular cancer	0.000189	0.000532	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—testicular cancer	0.000189	0.000532	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000187	0.000528	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—testicular cancer	0.000186	0.000525	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—testicular cancer	0.000185	0.000523	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000185	0.000522	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—testicular cancer	0.000185	0.000521	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—testicular cancer	0.000183	0.000517	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—testicular cancer	0.000182	0.000513	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—testicular cancer	0.000181	0.000511	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—testicular cancer	0.000181	0.000511	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000181	0.00051	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—testicular cancer	0.000179	0.000506	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—testicular cancer	0.000178	0.000502	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—testicular cancer	0.000177	0.000499	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—testicular cancer	0.000177	0.000498	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—testicular cancer	0.000176	0.000497	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000175	0.000494	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—testicular cancer	0.000174	0.000492	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—testicular cancer	0.000172	0.000486	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000171	0.000483	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—testicular cancer	0.000171	0.000482	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—testicular cancer	0.00017	0.00048	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—testicular cancer	0.00017	0.000478	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—testicular cancer	0.000169	0.000478	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—testicular cancer	0.000169	0.000478	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—testicular cancer	0.000169	0.000476	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—testicular cancer	0.000164	0.000463	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—testicular cancer	0.000163	0.000461	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000162	0.000457	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—testicular cancer	0.000162	0.000457	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—testicular cancer	0.000158	0.000445	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—testicular cancer	0.000157	0.000444	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—testicular cancer	0.000157	0.000442	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—testicular cancer	0.000157	0.000442	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—testicular cancer	0.000157	0.000442	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—testicular cancer	0.000154	0.000434	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—testicular cancer	0.000152	0.000428	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—testicular cancer	0.000151	0.000427	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—testicular cancer	0.000147	0.000414	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—testicular cancer	0.000146	0.000412	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—testicular cancer	0.000146	0.000411	CcSEcCtD
Lercanidipine—Rash—Methotrexate—testicular cancer	0.000144	0.000407	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—testicular cancer	0.000144	0.000407	CcSEcCtD
Lercanidipine—Headache—Methotrexate—testicular cancer	0.000143	0.000405	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—testicular cancer	0.000142	0.000401	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—testicular cancer	0.000142	0.0004	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—testicular cancer	0.00014	0.000396	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—testicular cancer	0.000136	0.000384	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—testicular cancer	0.000136	0.000384	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—testicular cancer	0.000136	0.000383	CcSEcCtD
Lercanidipine—Rash—Epirubicin—testicular cancer	0.000135	0.000381	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—testicular cancer	0.000135	0.000381	CcSEcCtD
Lercanidipine—Headache—Epirubicin—testicular cancer	0.000134	0.000379	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—testicular cancer	0.000131	0.00037	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—testicular cancer	0.000127	0.000359	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—testicular cancer	0.000126	0.000356	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—testicular cancer	0.000125	0.000353	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—testicular cancer	0.000125	0.000352	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—testicular cancer	0.000124	0.00035	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—testicular cancer	0.000118	0.000332	CcSEcCtD
